Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AdaptHealth (AHCO) Interest Expenses (2019 - 2024)

AdaptHealth has reported Interest Expenses over the past 6 years, most recently at $31.4 million for Q3 2024.

  • For Q3 2024, Interest Expenses fell 2.71% year-over-year to $31.4 million; the TTM value through Jun 2025 reached $31.4 million, down 76.06%, while the annual FY2023 figure was $130.3 million, 19.09% up from the prior year.
  • Interest Expenses for Q3 2024 was $31.4 million at AdaptHealth, down from $33.0 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $33.5 million in Q4 2023 and troughed at $7.5 million in Q2 2020.
  • A 5-year average of $24.9 million and a median of $25.6 million in 2021 define the central range for Interest Expenses.
  • On a YoY basis, Interest Expenses climbed as much as 453.26% in 2020 and fell as far as 48.88% in 2020.
  • Year by year, Interest Expenses stood at $13.6 million in 2020, then skyrocketed by 88.26% to $25.6 million in 2021, then rose by 19.12% to $30.5 million in 2022, then rose by 9.76% to $33.5 million in 2023, then decreased by 6.14% to $31.4 million in 2024.
  • Business Quant data shows Interest Expenses for AHCO at $31.4 million in Q3 2024, $33.0 million in Q2 2024, and $32.5 million in Q1 2024.